NEW YORK, July 14, Jul 14, 2014 (GLOBE NEWSWIRE via COMTEX) — NeoStem, Inc. (Nasdaq:NBS), a leader in the emerging cellular therapy industry, announced today that Frost & Sullivan has awarded the Company its 2014 North American Cell Therapeutics Technology Innovation Leadership Award. The award is part of Frost & Sullivan’s Best Practice Award series, recognizing companies that have demonstrated excellence in devising strong growth strategies and robustly implementing these approaches. NeoStem was recognized for its outstanding achievement and superiorRead more
- Duos Technologies Reports Record Second Quarter 2018 Results; Increases Full Year 2018 Revenue Guidance to $10.1 Million
- Argentum 47, Inc. is Formally Retained as Corporate Advisor to Creditum Limited, a Disruptive Technology Company Lending Money to Holders of Various Digital Currencies and Offering Other Financial Instruments
- Cannabis Strategic Ventures, Inc. Begins Production of Cannabis Filtration Device, Halo Filters
- eWellness is Developing a Tokenized Telehealth Payment System for the Healthcare Insurance Industry Update
- Golden Developing Solutions Expands Shareholder Communications
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More